Fig. 4From: Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinomaImmune cell deconvolution results using CIBERSORT on TCGA papillary thyroid tumors. A Wilcoxon test results comparing each LM22 component in TIMP3 quartile I vs IV. BH adjustment was applied. Significant p-values are highlighted in red. B Barplot of cell types from LM22 signature that were differentially represented by CIBERSORT deconvolution analysis in TIMP3 quartile I in comparison to quartile IV in TCGA-PTC samples. Relative percentages are reported for significantly enriched cell types in each groupBack to article page